Characteristics | Number (%) of patients |
---|---|
Drug therapy: | |
 Oseltamivir | 180 (97.3%) |
 Lopinavir-ritonavir | 2 (1.1%) |
 Ceftriaxone | 45 (24.3%) |
 Azithromycin | 5 (2.7%) |
 low molecular weight heparin | 179 (96.7%) |
 Antenatal steroid for lung maturation | 38 (20.5%) |
 Intensive care unit (ICU) admission | 2 (1.1%) |
 ECMO | 0 |
Final outcomes: | |
 Died | 0 |
 Discharged | 185 (100%) |
 Length of hospital stay, days (median, IQR) | 15 (14–22) |